
### [Orphanet:79262](http://www.orpha.net/ORDO/Orphanet_79262)
**Label:** Adult neuronal ceroid lipofuscinosis

**Subclasses:** [Orphanet:228343](http://www.orpha.net/ORDO/Orphanet_228343) (CLN4B disease), [Orphanet:228340](http://www.orpha.net/ORDO/Orphanet_228340) (CLN4A disease), [Orphanet:228363](http://www.orpha.net/ORDO/Orphanet_228363) (CLN6 disease), [Orphanet:228329](http://www.orpha.net/ORDO/Orphanet_228329) (CLN1 disease), [Orphanet:352709](http://www.orpha.net/ORDO/Orphanet_352709) (CLN13 disease), [Orphanet:314629](http://www.orpha.net/ORDO/Orphanet_314629) (CLN11 disease), [Orphanet:228337](http://www.orpha.net/ORDO/Orphanet_228337) (CLN10 disease), 

**Corr. equiv. classes:** [Orphanet:352709](http://www.orpha.net/ORDO/Orphanet_352709), [OMIM:601780](http://purl.obolibrary.org/obo/OMIM_601780), [Orphanet:228340](http://www.orpha.net/ORDO/Orphanet_228340), [Orphanet:228363](http://www.orpha.net/ORDO/Orphanet_228363), [OMIM:162350](http://purl.obolibrary.org/obo/OMIM_162350), [Orphanet:228343](http://www.orpha.net/ORDO/Orphanet_228343), [OMIM:615362](http://purl.obolibrary.org/obo/OMIM_615362), [OMIM:256730](http://purl.obolibrary.org/obo/OMIM_256730), [OMIM:204300](http://purl.obolibrary.org/obo/OMIM_204300), [Orphanet:314629](http://www.orpha.net/ORDO/Orphanet_314629), [OMIM:610127](http://purl.obolibrary.org/obo/OMIM_610127), [Orphanet:228337](http://www.orpha.net/ORDO/Orphanet_228337), [OMIM:614706](http://purl.obolibrary.org/obo/OMIM_614706), [Orphanet:228329](http://www.orpha.net/ORDO/Orphanet_228329), 

**Class expressions from DL-Learner:**

- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) 64.29%
- [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) 64.29%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 64.29%
- [HP:0001317](http://purl.obolibrary.org/obo/HP_0001317) (Abnormality of the cerebellum) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 64.29%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 64.29%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 64.29%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 64.29%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0002074](http://purl.obolibrary.org/obo/HP_0002074) (Increased neuronal autofluorescent lipopigment) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 64.29%


